Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma
- PMID: 26319790
- DOI: 10.1007/s10238-015-0382-1
Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma
Abstract
Vascular endothelial growth factor (VEGF) has been linked with tumor invasion and metastasis. However, the role of VEGF expression in osteosarcoma remains controversial. By searching the PubMed, Embase, and Google Scholar databases, we conducted a meta-analysis to evaluate the pathological and prognostic significance of VEGF in osteosarcoma. Studies were pooled, and the odds ratio (OR) and its corresponding 95 % confidence interval (CI) were calculated. Nine relevant articles were included in this meta-analysis study. We performed pooled analysis with available data on the association between VEGF expression and age, gender, tumor stages IIB-III versus I-IIA, tumor recurrence, response to chemotherapy, and tumor metastasis. Our results revealed that VEGF expression might be closely associated with metastasis of osteosarcoma (OR 4.74, 95 % CI 2.53-8.87, P < 0.001). Furthermore, our findings also demonstrated that patients with grade IIB-III osteosarcoma showed a higher frequency of VEGF expression than those with grade I-IIA osteosarcoma (OR 5.33, 95 % CI 2.03-13.98, P = 0.001). We failed to find the association between VEGF expression and age (OR 0.82, 95 % CI 0.44-1.53, P = 0.539), gender (OR 1.33, 95 % CI 0.52-3.42, P = 0.553), tumor recurrence (OR 1.47, 95 % CI 0.56-3.86, P = 0.429), and response to chemotherapy (OR 1.26, 95 % CI 0.14-11.72, P = 0.839). In conclusion, VEGF is related to the grade and metastasis of osteosarcoma. It may play a significant role in clinical guidelines for the treatment and prognostic evaluation.
Keywords: Meta-analysis; Osteosarcoma; Pathological characteristics; Prognosis; Vascular endothelial growth factor.
Similar articles
-
The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.J Orthop Surg Res. 2021 Dec 28;16(1):738. doi: 10.1186/s13018-021-02888-3. J Orthop Surg Res. 2021. PMID: 34963495 Free PMC article. Review.
-
Prognostic Significance of Survivin Expression in Osteosarcoma Patients: A Meta-Analysis.Med Sci Monit. 2015 Sep 25;21:2877-85. doi: 10.12659/MSM.894448. Med Sci Monit. 2015. PMID: 26408642 Free PMC article.
-
Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.Future Oncol. 2017 Sep;13(21):1883-1891. doi: 10.2217/fon-2017-0180. Epub 2017 Aug 2. Future Oncol. 2017. PMID: 28766969
-
Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.Pathol Res Pract. 2008;204(8):575-82. doi: 10.1016/j.prp.2008.01.015. Epub 2008 Apr 28. Pathol Res Pract. 2008. PMID: 18440723
-
A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.Tumour Biol. 2013 Jun;34(3):1895-9. doi: 10.1007/s13277-013-0733-z. Epub 2013 Apr 16. Tumour Biol. 2013. PMID: 23589053 Review.
Cited by
-
The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.J Orthop Surg Res. 2021 Dec 28;16(1):738. doi: 10.1186/s13018-021-02888-3. J Orthop Surg Res. 2021. PMID: 34963495 Free PMC article. Review.
-
The prognostic role of CD133 expression in patients with osteosarcoma.Clin Exp Med. 2020 May;20(2):261-267. doi: 10.1007/s10238-020-00607-6. Epub 2020 Feb 12. Clin Exp Med. 2020. PMID: 32048073
-
Osteosarcoma and Metastasis.Front Oncol. 2021 Dec 10;11:780264. doi: 10.3389/fonc.2021.780264. eCollection 2021. Front Oncol. 2021. PMID: 34956899 Free PMC article. Review.
-
Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.Clin Exp Med. 2017 Feb;17(1):59-69. doi: 10.1007/s10238-015-0405-y. Epub 2015 Dec 17. Clin Exp Med. 2017. PMID: 26678086
-
Prognostic and Therapeutic Utility of Variably Expressed Cell Surface Receptors in Osteosarcoma.Sarcoma. 2021 Feb 2;2021:8324348. doi: 10.1155/2021/8324348. eCollection 2021. Sarcoma. 2021. PMID: 33603563 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical